Table 2.
Characteristics of participants in training group and test group.
| Characteristics | Training group | Test group | ||
|---|---|---|---|---|
| GRs (n = 116) | Non-GRs (n = 384) | GRs (n = 60) | Non-GRs (n = 140) | |
| Age (years) | P = 0.868 (t = 0.167) | P = 0.519 (t = 0.646) | ||
| 56.14 ± 11.76 | 55.94 ± 10.84 | 57.73 ± 10.80 | 56.68 ± 10.50 | |
| Gender (%) | P = 0.303 (χ 2 = 1.061) | P = 0.124 (χ 2 = 0.724) | ||
| Male | 71 (61.2) | 255 (66.4) | 37 (61.7) | 90 (64.3) |
| Female | 45(38.8) | 129 (33.6) | 23 (38.3) | 50 (35.7) |
| Pretreatment T-stage | P = 0.059 (χ 2 = 7.445) | P = 1.093 (χ 2 = 0.779) | ||
| T2 | 17 (14.7) | 30 (7.8) | 3 (5.0) | 7 (5.0) |
| T3 | 82 (70.7) | 294(76.6) | 44 (73.3) | 93 (66.4) |
| T4a | 5 (4.3) | 31 (8.1) | 8 (13.3) | 26 (18.6) |
| T4b | 12 (10.3) | 29 (7.6) | 5 (8.3) | 14 (10.0) |
| Pretreatment N-stage | P = 0.406 (χ 2 = 3.999) | P = 0.688 (χ 2 = 2.260) | ||
| N0 | 8 (6.9) | 19 (4.9) | 1 (1.7) | 3 (2.1) |
| N1a | 9 (7.8) | 16 (4.2) | 2 (3.3) | 5 (3.6) |
| N1b | 18(15.5) | 51 (13.3) | 7 (11.7) | 8 (5.7) |
| N2a | 27 (23.3) | 103 (26.8) | 21 (35.0) | 49 (35.0) |
| N2b | 54 (46.6) | 195 (50.8) | 29 (48.3) | 75 (53.6) |
| ADC (10-3mm2/sec) | P = 0.000 (T = 3.937) | P = 0.000 (T = 4.439) | ||
| 1.05 ± 0.17 | 1.11 ± 0.13 | 1.01 ± 0.16 | 1.11 ± 0.10 | |